Study of selnoflast for heart artery inflammation
Part of Heart & circulation clinical trials.
This trial tests a drug called selnoflast to see if it can reduce inflammation in the arteries of people with atherosclerosis (hardening of the arteries) who are at risk for heart attacks or other serious heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atherosclerosis confirmed by a doctor
- A special scan (PET scan) shows a certain level of inflammation in your neck or aorta arteries
- You are already on treatments for atherosclerosis that are stable
- Your heart's electrical activity (QT interval) is within a safe range
- You do not have severe heart failure or uncontrolled heart rhythm problems
- You have not had cancer in the last 5 years (except certain minor skin cancers) and do not have active hepatitis B, C, or HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
This trial tests selatogrel to see if it can better prevent harmful heart and blood-clot outcomes after a recent heart attack. You may be considered if you had a heart attack in the past 4 weeks and have higher-risk heart artery disease.
This trial is tracking the long-term safety and effectiveness of a sirolimus-eluting balloon (Selution SLR) in people with coronary artery disease. It aims to see how well this device works when used to open blocked arteries in real-world medical practice.
This trial studies a drug-coated balloon (plus standard heart medicines) to treat a specific type of blockage in the heart arteries in people who need an intervention. It may help keep the artery open and prevent the narrowing from coming back, depending on how well you match the detailed heart and medication requirements.
This study tests a natural supplement (polyglucosamine) that may help reduce fat absorption, aiming to prevent heart disease and stroke. It is for people with high blood pressure, diabetes, or high cholesterol who also have early signs of artery thickening.
This trial uses advanced ultrasound techniques to get detailed images of carotid artery plaque. It aims to better understand plaque characteristics, which could help guide treatment decisions for people with significant narrowing in their carotid artery.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.